Heterogenous specific binding assay employing a coenzyme as label

• US 4,230,797 A
• Filed: 04/10/1978
• Issued: 10/28/1980
• Est. Priority Date: 04/28/1975
• Status: Expired due to Term

• Current Assignee: Miles Laboratories, Inc. (Bayer AG)
• Original Assignee: Miles Laboratories, Inc. (Bayer AG)
• Inventors: Christner, James E., Carrico, Robert J., Boguslaski, Robert C.
• Primary Examiner(s): Wiseman, Thomas G.
• Application Number:
  US05/894,838
• Time in Patent Office: 932 Days
• Field of Search: 23/230 B, 195/99, 195/103.5 A, 195/103.5 R, 424/8, 424/12, 435/7, 435/810
• US Class Current: 435/7.23
• CPC Class Codes: C07D 209/48 with oxygen atoms in positions 1 and 3, e.g. phthalimide
• CPC Class Codes: C07D 237/32 with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
• CPC Class Codes: C07D 495/04 Ortho-condensed systems
• CPC Class Codes: C07H 19/20 with the saccharide radical esterified by phosphoric or polyphosphoric acids
• CPC Class Codes: G01N 33/535 with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
• CPC Class Codes: G01N 33/537 with separation of immune complex from unbound antigen or antibody
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/962 Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
• CPC Class Codes: Y10S 435/966 involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems
• CPC Class Codes: Y10S 435/968 High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
• CPC Class Codes: Y10S 435/971 Capture of complex after antigen-antibody reaction
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/815 Test for named compound or class of compounds

Abstract

An improved heterogeneous specific binding assay method which employs a substance having reactant activity, i.e., a reactant, as a labeling substance in the detection of a ligand in a liquid medium. The method is carried out using reagent means which comprises, as its labeled constituent, a conjugate formed of a specific binding substance coupled to the reactant. The reactant advantageously is an enzymatic reactant such as an enzyme substrate or coenzyme. The activity of the conjugated reactant as a constituent of a predetermined reaction system is utilized as means for monitoring the extent of binding of the labeled constituent in conventional heterogeneous specific binding assay schemes. The presence of a ligand in a liquid medium may be determined following conventional competitive binding manipulative techniques. After the necessary separation of the bound-and free-phases resulting in the specific binding reaction system, the extent of binding of the labeled constituent is determined by contacting either phase with the necessary materials to form the predetermined monitoring reaction system in which the labeling substance is active and assessing reactant activity therein.

Claims

1. In a heterogeneous specific binding assay method for determining a ligand in a liquid medium, which method comprises the steps of:

(a) contacting said liquid medium with reagent means including a labeled conjugate comprising a specific binding substance coupled to a labeling substance, said reagent system producing

(1) a bound-phase of the labeled conjugate in which the specific binding substance therein is bound by a specific binding partner thereto and

(2) a free-phase of the labeled conjugate in which the specific binding substance therein is not bound by a specific binding partner thereto,

(b) separating said bound-phase and said free-phase; and

(c) determining said labeling substance in said bound-phase or said free-phase as a function of the amount of said ligand in said liquid medium;

the improvement wherein said labeling substance in said labeled conjugate is a nucleotide coenzyme, and wherein said labeling substance measuring the extent to which said coenzyme participates in an enzymatic reaction involving an enzyme which requires said coenzyme for activity.

2. A method as in claim 1 wherein said nucleotide coenzyme is selected from the group consisting of the adenosine phosphates. nicotinamide adenine dinucleotide and reduced forms thereof, and nicotinamide adenine dinucleotide phosphate and reduced forms thereof.

3. A method as in claim 1 wherein said nucleotide coenzyme is nicotinamide adenine dinucleotide or a reduced form thereof.

4. A method as in claim 1 wherein said nucleotide coenzyme is adenosine triphosphate.

5. A method as in claim 1 wherein said nucleotide coenzyme is flavin adenine dinucleotide.

6. A method as in claim 1 wherein said enzymatic reaction is cyclic.

7. A method as in claim 6 wherein said coenzyme-active labeling substance is a cycled reagent in said cyclic reaction.

8. A method as in claim 1 wherein said enzymatic reaction is chemiluminescent.

9. A method as in claim 1 wherein said ligand is selected from the group consisting of antigens and antibodies thereto;

haptens and antibodies thereto; and

hormones, vitamins, metabolites, and pharmacological agents, and their receptors and binding substances.

10. A method as in claim 1 wherein said liquid medium is a biological fluid.

11. In a reagent means for use in determining a ligand in a liquid medium, which means comprises (i) a labeled conjugate comprising said ligand or a specific binding analog thereof coupled to a labeling substance, and (ii) a specific binding partner of said ligand which binding partner is in a form which is insoluble in said liquid medium,

the improvement wherein said labeling substance in said labeled conjugate is a nucleotide coenzyme.

12. Means as in claim 11 wherein said nucleotide coenzyme is selected from the group consisting of the adenosine phosphates, nicotinamide adenine dinucleotide and reduced forms thereof, and nicotinamide adenine dinucleotide phosphate and reduced forms thereof.

13. Means as in claim 11 wherein said nucleotide coenzyme is nicotinamide adenine dinucleotide or a reduced form thereof.

14. Means as in claim 11 wherein said nucleotide coenzyme is adenosine triphosphate.

15. Means as in claim 11 wherein said nucleotide coenzyme is flavin adenine dinucleotide.

16. Means as in claim 11 wherein said ligand is selected from the group consisting of antigens and antibodies thereto;

haptens and antibodies thereto; and

hormones, vitamins, metabolites, and pharmacological agents, and their receptors and binding substances.

17. Means as in claim 11 wherein at least one of the components of said means is incorporated with a carrier that is insoluble in said liquid medium.

18. Means as in claim 17 wherein said carrier is a matrix that is absorbent relative to said liquid medium.

19. In a reagent means for use in determining a ligand in a liquid medium, which means comprises (i) a labeled conjugate comprising a specific binding partner of said ligand coupled to a labeling substance, and (ii) a specific binding partner of said ligand which binding partner is in a form which is insoluble in said liquid medium,

the improvement wherein said labeling substance in said labeled conjugate is a nucleotide coenzyme.

20. Means as in claim 19 wherein said nucleotide coenzyme is selected from the group consisting of the adenosine phosphates, nicotinamide adenine dinucleotide and reduced forms thereof, and nicotinamide adenine dinucleotide phosphates and reduced forms thereof.

21. Means as in claim 19 wherein said nucleotide coenzyme is nicotinamide adenine dinucleotide or a reduced form thereof.

22. Means as in claim 19 wherein said nucleotide coenzyme is adenosine triphosphate.

23. Means as in claim 19 wherein said nucleotide coenzyme is flavin adenine dinucleotide.

24. Means as in claim 19 wherein said ligand is selected from the group consisting of antigens and antibodies thereto;

haptens and antibodies thereto; and

hormones, vitamins, metabolites, and pharmacological agents, and their receptors and binding substances.

25. Means as in claim 19 wherein at least one of the components of said means is incorporated with a carrier that is insoluble in said liquid medium.

26. Means as in claim 25 wherein said carrier is a matrix that is absorbent relative to said liquid medium.